Authors:
MOSS RB
TRAUGER RJ
GIERMAKOWSKA WK
TURNER JL
WALLACE MR
JENSEN FC
RICHIERI SP
FERRE F
DAIGLE AE
DUFFY C
THEOFAN G
CARLO DJ
Citation: Rb. Moss et al., EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETED HIV-1 IMMUNOGEN ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTS WITH HIV-1 INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 343-350
Authors:
MOSS RB
TRAUGER RJ
GIERMAKOWSKA WK
TURNER JL
WALLACE MR
RICHIERI SP
FERRE F
DAIGLE AE
DUFFY C
THEOFAN G
CARLO DJ
JENSEN FC
Citation: Rb. Moss et al., EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120 DEPLETED HIV-1 IMMUNOGEN (REMUNE(TM) ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTSWITH HIV-1 INFECTION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 193-193
Authors:
LEVINE AM
GROSHEN S
ALLEN J
MUNSON KM
CARLO TJ
DAIGLE AE
FERRE F
JENSEN FC
RICHIERI SP
TRAUGER RJ
PARKER JW
SALK PL
SALK J
Citation: Am. Levine et al., INITIAL STUDIES ON ACTIVE IMMUNIZATION OF HIV-INFECTED SUBJECTS USINGA GP120-DEPLETED HIV-1 IMMUNOGEN - LONG-TERM FOLLOW-UP, Journal of acquired immune deficiency syndromes and human retrovirology, 11(4), 1996, pp. 351-364
Authors:
FERRE F
MOSS RB
DAIGLE AE
TRAUGER RJ
RICHIERI SP
JENSEN FC
CARLO DJ
Citation: F. Ferre et al., COMBINATION THERAPIES AGAINST HIV-1 INFECTION - EXPLORING THE CONCEPTOF COMBINING ANTIRETROVIRAL DRUG TREATMENTS WITH HIV-1 IMMUNE-BASED THERAPIES IN ASYMPTOMATIC INDIVIDUALS, AIDS patient care, 10(6), 1996, pp. 357-361
Authors:
MOSS RB
FERRE F
LEVINE A
TURNER J
JENSEN FC
DAIGLE AE
RICHIERI SP
TRUCKENBROD A
TRAUGER RJ
CARLO DJ
SALK J
Citation: Rb. Moss et al., VIRAL LOAD, CD4 PERCENTAGE, AND DELAYED-TYPE HYPERSENSITIVITY IN SUBJECTS RECEIVING THE HIV-1 IMMUNOGEN AND ANTIVIRAL DRUG-THERAPY, Journal of clinical immunology, 16(5), 1996, pp. 266-271
Authors:
TRAUGER RJ
DAIGLE AE
GIERMAKOWSKA W
MOSS RB
JENSEN F
CARLO DJ
Citation: Rj. Trauger et al., SAFETY AND IMMUNOGENICITY OF A GP120-DEPLETED, INACTIVATED HIV-1 IMMUNOGEN - RESULTS OF A DOUBLE-BLIND, ADJUVANT CONTROLLED TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 74-82
Authors:
TRAUGER RJ
GIERMAKOWSKA W
WORMSLEY S
TURNER J
JENSEN FC
CARLO DJ
Citation: Rj. Trauger et al., AUTOPROLIFERATION IN HIV-1-INFECTED PATIENTS UNDERGOING ACTIVE HIV-1-SPECIFIC IMMUNOTHERAPY, Clinical and experimental immunology, 100(1), 1995, pp. 7-12
Authors:
TRAUGER RJ
GIERMAKOWSKA W
COX J
LUCAS M
JENSEN F
CARLO D
Citation: Rj. Trauger et al., SEROLOGICAL AND CELL-MEDIATED IMMUNE-RESPONSE AFTER IMMUNIZATION WITHAN ENVELOPE DEPLETED INACTIVATED HIV-1 IMMUNOGEN - RESULTS OF A 1 YEAR DOUBLE-BLIND ADJUVANT CONTROLLED TRIAL, AIDS research and human retroviruses, 10, 1994, pp. 190000159-190000159
Citation: Jl. Turner et al., HIV-1 IMMUNOGEN INDUCTION OF HIV-1-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY - RESULTS OF A DOUBLE-BLIND, ADJUVANT-CONTROLLED, DOSE-RANGING TRIAL, AIDS, 8(10), 1994, pp. 1429-1435
Authors:
TRAUGER RJ
FERRE F
DAIGLE AE
JENSEN FC
MOSS RB
MUELLER SH
RICHIERI SP
SLADE HB
CARLO DJ
Citation: Rj. Trauger et al., EFFECT OF IMMUNIZATION WITH INACTIVATED GP120-DEPLETED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IMMUNOGEN ON HIV-1 IMMUNITY, VIRAL-DNA, AND PERCENTAGE OF CD4 CELLS, The Journal of infectious diseases, 169(6), 1994, pp. 1256-1264
Authors:
BOYER V
SMITH LR
FERRE F
PEZZOLI P
TRAUGER RJ
JENSEN FC
CARLO DJ
Citation: V. Boyer et al., T-CELL RECEPTOR V-BETA REPERTOIRE IN HIV-INFECTED INDIVIDUALS - LACK OF EVIDENCE FOR SELECTIVE V-BETA DELETION, Clinical and experimental immunology, 92(3), 1993, pp. 437-441